Ionis Pharmaceuticals | بدهی های جاری

قیمت سهام
83.94
تغییر روزانه
0.79 0.95%
ماهیانه
3.63%
سالیانه
163.22%
Q1 پیش بینی
80.57




بدهی های جاری تغییر دادن تاریخ
Agios Pharmaceuticals USD 82.21M 7.45M 2025-12
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Arrowhead Research USD 347.42M 151.94M 2025-12
Astellas Pharma JPY 1.32T 873M 2025-12
BioCryst Pharmaceuticals USD 190.24M 13.08M 2025-09
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Celltrion KRW 4.01T 343.96B 2025-09
Cspc Pharmaceutical CNY 10.11B 478.47M 2025-06
Deva Holding AS TRY 6.43B 1.18B 2023-09
Divis Laboratories Ltd INR 17.28B 2.76B 2025-09
Esperion Therapeutics USD 359.03M 60.24M 2025-09
Exelixis USD 405.64M 31.86M 2025-12
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
Ionis Pharmaceuticals USD 903.46M 6.22M 2025-09
Kangmei Pharma CNY 5.81B 57.93M 2025-09
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 7.82M 1.45M 2025-06
Moderna USD 1.99B 306M 2025-12
Nektar Therapeutics USD 66.34M 5.05M 2025-09
Neuren Pharmaceuticals AUD 7.92M 37.84M 2025-06
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Novartis USD 32B 286M 2025-09
Omeros USD 85.5M 2.28M 2025-06
OPKO Health USD 169.32M 1.86M 2025-09
Organigram Holdings CAD 126.16M 18.88M 2025-09
Ovoca Bio EUR 2.44M 1.1M 2022-06
Pfizer USD 36.6B 1.13B 2025-09
Pharma Mar EUR 88.93M 1.15M 2025-09
PTC Therapeutics USD 968.43M 102.18M 2025-12
Qiagen NV USD 512.14M 461.26M 2025-12
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Roche Holding CHF 28B 421M 2025-12
Sarepta Therapeutics USD 921.42M 1.48M 2025-09
Sartorius EUR 1.81B 254.3M 2025-09
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Tilray USD 280.3M 18.13M 2025-03
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12
Zz Pientze Pharmaceu CNY 2.14B 1.06B 2025-09


Ionis Pharmaceuticals بدهی های جاری - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Feb 2026.